Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 3
1999 4
2000 2
2001 5
2002 3
2003 4
2004 6
2005 9
2006 2
2007 5
2008 10
2009 12
2010 10
2011 12
2012 12
2013 12
2014 9
2015 18
2016 16
2017 13
2018 19
2019 15
2020 17
2021 33
2022 34
2023 20
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

279 results

Results by year

Filters applied: . Clear all
Page 1
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis.
Trougakos IP, Terpos E, Alexopoulos H, Politou M, Paraskevis D, Scorilas A, Kastritis E, Andreakos E, Dimopoulos MA. Trougakos IP, et al. Among authors: paraskevis d. Trends Mol Med. 2022 Jul;28(7):542-554. doi: 10.1016/j.molmed.2022.04.007. Epub 2022 Apr 21. Trends Mol Med. 2022. PMID: 35537987 Free PMC article. Review.
A global scientific strategy to cure hepatitis B.
Revill PA, Chisari FV, Block JM, Dandri M, Gehring AJ, Guo H, Hu J, Kramvis A, Lampertico P, Janssen HLA, Levrero M, Li W, Liang TJ, Lim SG, Lu F, Penicaud MC, Tavis JE, Thimme R; Members of the ICE-HBV Working Groups; ICE-HBV Stakeholders Group Chairs; ICE-HBV Senior Advisors; Zoulim F. Revill PA, et al. Lancet Gastroenterol Hepatol. 2019 Jul;4(7):545-558. doi: 10.1016/S2468-1253(19)30119-0. Epub 2019 Apr 10. Lancet Gastroenterol Hepatol. 2019. PMID: 30981686 Free PMC article.
Real-world Effectiveness of Molnupiravir and Nirmatrelvir/Ritonavir as Treatments for COVID-19 in Patients at High Risk.
Paraskevis D, Gkova M, Mellou K, Gerolymatos G, Psalida N, Gkolfinopoulou K, Kostaki EG, Loukides S, Kotanidou A, Skoutelis A, Thiraios E, Saroglou G, Zografopoulos D, Filippou D, Mossialos E, Zaoutis T, Gaga M, Tsiodras S, Antoniadou A. Paraskevis D, et al. J Infect Dis. 2023 Dec 20;228(12):1667-1674. doi: 10.1093/infdis/jiad324. J Infect Dis. 2023. PMID: 37565522 Free PMC article.
Editorial.
Paraskevis D, Ayouba A, Peeters M. Paraskevis D, et al. Infect Genet Evol. 2016 Dec;46:149. doi: 10.1016/j.meegid.2016.11.017. Infect Genet Evol. 2016. PMID: 27914559 No abstract available.
A multinational Delphi consensus to end the COVID-19 public health threat.
Lazarus JV, Romero D, Kopka CJ, Karim SA, Abu-Raddad LJ, Almeida G, Baptista-Leite R, Barocas JA, Barreto ML, Bar-Yam Y, Bassat Q, Batista C, Bazilian M, Chiou ST, Del Rio C, Dore GJ, Gao GF, Gostin LO, Hellard M, Jimenez JL, Kang G, Lee N, Matičič M, McKee M, Nsanzimana S, Oliu-Barton M, Pradelski B, Pyzik O, Rabin K, Raina S, Rashid SF, Rathe M, Saenz R, Singh S, Trock-Hempler M, Villapol S, Yap P, Binagwaho A, Kamarulzaman A, El-Mohandes A; COVID-19 Consensus Statement Panel. Lazarus JV, et al. Nature. 2022 Nov;611(7935):332-345. doi: 10.1038/s41586-022-05398-2. Epub 2022 Nov 3. Nature. 2022. PMID: 36329272 Free PMC article.
Primate immunodeficiency virus classification and nomenclature: Review.
Foley BT, Leitner T, Paraskevis D, Peeters M. Foley BT, et al. Among authors: paraskevis d. Infect Genet Evol. 2016 Dec;46:150-158. doi: 10.1016/j.meegid.2016.10.018. Epub 2016 Oct 24. Infect Genet Evol. 2016. PMID: 27789390 Free PMC article. Review.
Pre-Exposure Prophylaxis for HIV: Evidence and Perspectives.
Nikolopoulos GK, Christaki E, Paraskevis D, Bonovas S. Nikolopoulos GK, et al. Among authors: paraskevis d. Curr Pharm Des. 2017;23(18):2579-2591. doi: 10.2174/1381612823666170329145053. Curr Pharm Des. 2017. PMID: 28356043 Review.
Recent Advances in Antiretroviral Agents: Potent Integrase Inhibitors.
Psichogiou M, Poulakou G, Basoulis D, Paraskevis D, Markogiannakis A, Daikos GL. Psichogiou M, et al. Among authors: paraskevis d. Curr Pharm Des. 2017;23(18):2552-2567. doi: 10.2174/1381612823666170329142059. Curr Pharm Des. 2017. PMID: 28356041 Review.
279 results